“…The pharmaceutical industry, driven by the FDA ' s PAT initiative, can be seen as a forerunner. This is refl ected by the observation that many references in this chapter are (co -) authored by representatives from pharmaceutical companies like Glaxo Wellcome 21,29 and GlaxoSmithKline, 8,10,36,39,40 Astra Zeneca, 19,38 Novartis 28 and Eli Lilly. 18 As with other spectroscopic techniques, UV -vis spectroscopy can readily be used in lab -based R & D. The implementation as process monitors, scanning for deviations from the set state, is certainly an added value and low in maintenance requirements.…”